You are here

Article Text

Article menu
Download PDFPDF
CASE REPORT
Pulmonary inflammatory myofibroblastic tumour after Hodgkin's lymphoma
  1. Vesna Ilic1,
  2. Vincent Dunet2,
  3. Maja Beck-Popovic3,
  4. Ariane Boubaker1
  1. 1Department of Nuclear Medicine, Lausanne University Hospital, Lausanne, Switzerland
  2. 2Department of Radiology, Lausanne University Hospital, Lausanne, Switzerland
  3. 3Department of Pediatric Hematology-Oncology Unit, Lausanne University Hospital, Lausanne, Switzerland
  1. Correspondence to Dr Vincent Dunet, vincent.dunet{at}chuv.ch

Summary

Positron emission tomography (PET)/CT plays a major role in staging, assessing response to treatment and during follow-up of paediatric Hodgkin's lymphoma (HL). Owing to high sensitivity to detect viable tumoural tissue, negative PET/CT is highly predictive of survival. However, 18F-FDG is not specific for malignant disease and may concentrate in numerous benign/inflammatory lesions that may cause ‘false-positive’ results and follow-up PET/CT studies should be interpreted with caution. We report a case of pulmonary inflammatory myofibroblastic tumour, which developed during follow-up in a young patient with complete remission of a stage IIB HL and was fully treated with surgical resection.

https://doi.org/10.1136/bcr-2013-202491

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text